🇺🇸

US SEC Filing Intelligence

· daily

Big Pharma Approvals — May 22, 2026

During this period, the FDA issued 2 approvals, both classified as 'FALLBACK' type with bullish signals, comprising 1 NME (BAXDROSTAT) and 1 label expansion (VENETOCLAX). The dominant therapeutic area theme is hematology-oncology, with both approvals targeting blood cancers. The highest-conviction signal is AstraZeneca's NME approval of BAXDROSTAT (BAXFENDY) with Priority Review, representing a novel therapy with strong regulatory endorsement and significant commercial potential. A key risk is the lack of disclosed peak sales estimates and exclusivity data, limiting precise valuation, though the bullish signals suggest favorable market reception. No biosimilars or bearish signals were recorded, indicating a clean, catalyst-rich period for the sector.

2 total filings
· daily

Orphan Drug Approvals — May 22, 2026

This digest covers 4 label expansion approvals from May 15-20, 2026, with zero NMEs, biosimilars, or first-cycle new indications. All four approvals are classified as 'FALLBACK' type and carry bullish signals of moderate strength (5/10) and materiality (5/10), but lack disclosed commercial data. The dominant therapeutic area is oncology, with three of four approvals targeting cancer indications. The highest-conviction signal is the dual label expansion for Daiichi Sankyo's ENHERTU (fam-trastuzumab deruxtecan-nxki), which received two separate approvals on the same day, signaling aggressive lifecycle management and potential market expansion for this blockbuster ADC. A key watch item is the lack of specificity in approval details—without disclosed peak sales, exclusivity, or pricing data, the investment thesis remains opaque and requires follow-up from sponsor disclosures or clinical trial readouts.

4 total filings
· daily

New Drug Approvals (Original) — May 22, 2026

The May 22, 2026 FDA approval digest is dominated by 10 'Other' approvals, with zero NMEs, zero biosimilars (as formally classified), and zero label expansions. The sole bullish signal is AstraZeneca's NME approval of BAXDROSTAT (BAXFENDY), granted Priority Review, representing the highest-conviction event in an otherwise low-catalyst period. The remaining nine approvals are all generic/biosimilar entries for mature molecules (linaclotide, mirtazapine, venetoclax, tadalafil, etc.) from sponsors including Actavis, Dr. Reddy’s, and Zydus, generating neutral signals due to lack of disclosed commercial data. Key risk: the absence of NMEs or label expansions signals a quiet period for innovative catalysts, though AstraZeneca’s Priority Review NME provides a differentiated pipeline signal.

10 total filings
· daily

DHS Homeland Security Contracts — May 22, 2026

The two DHS contracts awarded on May 19-20, 2026, totaling $267.5 million, are entirely civilian (DHS/CBP) and signal sustained investment in Southwest border security infrastructure and aviation assets. The highest-conviction signal is Davenport Aviation Inc.'s $95.5 million firm-fixed-price award for 10 H125 helicopters, which carries high execution risk due to zero outlayed funds and a compressed 2-year delivery timeline. LMI Consulting's $172 million quality assurance contract for border wall construction provides a steady ~$62.5 million annual revenue stream but is limited by no options beyond the base period. Key risks include firm-fixed-price execution on both contracts and potential budget volatility under a continuing resolution, while opportunities lie in follow-on DHS aviation and border infrastructure spending.

2 total filings
· daily

VA Healthcare & Services Contracts — May 22, 2026

This digest covers a single $153.1M civilian contract from the Department of Veterans Affairs awarded to GOVCIO, LLC, with no defense-related exposure. The contract, a time-and-materials delivery order for portfolio products and sustainment, signals stable but unremarkable revenue for GOVCIO through March 2026, with medium execution risk due to the pricing model. The highest-conviction signal is neutral, reflecting a large, competitive win that lacks a clear competitive moat or set-aside advantage. Key risks include medium pricing risk from the time-and-materials structure and potential revenue concentration for GOVCIO on this single award.

1 total filings
· daily

New Federal Contractors — May 22, 2026

This digest covers $913.4 million in new federal contract obligations awarded across six contracts, all civilian (0/6 defense-related), with an average signal strength of 5.5/10. The dominant theme is civilian agency IT modernization and border security infrastructure, led by the Department of Homeland Security (two contracts totaling $267.5M) and the General Services Administration (one $296.8M award). The highest-conviction signal is a bullish sole-source 8(a) award to Akumen, Inc. ($91.7M) from the State Department, indicating durable non-competitive revenue. A key risk is the unusual negative outlayed amount (-$13,398) on the largest contract (General Dynamics Information Technology, $296.8M), which may signal execution or accounting issues. Overall, the digest points to stable civilian spending but limited defense exposure and mixed execution signals.

6 total filings
· daily

Significant Contract Modifications ($10M+) — May 22, 2026

This digest covers six civilian agency contract actions totaling $913.4 million, with zero defense-related awards, underscoring a pure civilian-sector procurement story. The dominant theme is border security and IT modernization, led by a $296.8M General Dynamics Information Technology engineering services award from GSA and a $172.0M LMI Consulting border wall quality assurance order from DHS/CBP. The highest-conviction signal is a sole-source 8(a) award to Akumen, Inc. for $91.7M from the State Department, indicating durable non-competitive revenue. A key risk is the negative outlayed amount (-$13,398) on the GDIT contract, which raises execution status questions, and the high fixed-price risk on the $95.5M Davenport Aviation helicopter order and the $104.4M Carahsoft Salesforce license deal.

6 total filings
· daily

Contract Deobligations Alert — May 22, 2026

This digest covers $913.4 million in total obligations across 6 contracts, all civilian (0% defense), signaling a notable concentration of federal spending outside the Department of Defense. The dominant theme is border security and IT modernization, with the Department of Homeland Security (DHS) accounting for $267.5 million across two awards to LMI Consulting and Davenport Aviation, both tied to Southwest border infrastructure. The highest-conviction signal is Akumen, Inc.'s $91.7 million sole-source 8(a) award from the State Department, which offers revenue certainty with limited competitive pressure. A key risk is the General Dynamics Information Technology contract's negative outlayed amount (-$13,398), which may indicate execution issues or accounting anomalies that warrant monitoring.

6 total filings
· daily

Federal Professional Services Contracts — May 22, 2026

Over a single-day period, two federal professional services contracts totaling $468.8 million were awarded, both civilian in nature with zero defense exposure. The dominant theme is infrastructure quality assurance and engineering support, with the General Services Administration (GSA) and Department of Homeland Security (DHS) as the key agencies. The highest-conviction signal is General Dynamics Information Technology's $296.8 million GSA engineering services award, though its materiality is tempered by a negative outlayed amount (-$13,398) that raises execution ambiguity. A key risk is the fixed-price structure of LMI Consulting's $172.0 million border wall quality assurance contract, which shifts cost overrun risk to the contractor and lacks options for upside. Overall, the digest reflects stable but non-transformative civilian services spending, with no bullish or bearish signals flagged.

2 total filings
· daily

Federal IT & Cybersecurity Contracts — May 22, 2026

This digest covers $349.2 million in federal IT and cybersecurity contracts awarded entirely by civilian agencies (0% defense), signaling sustained non-defense digital modernization spending. The Department of Veterans Affairs ($153.1M to GOVCIO), USDA ($104.4M to Carahsoft), and Department of State ($91.7M to Akumen) dominate, with a clear theme of enterprise SaaS adoption and IT sustainment. The highest-conviction signal is Akumen's sole-source 8(a) award, which provides durable revenue with no competitive pressure through October 2026. Key risk: Carahsoft's fixed-price Salesforce ELA carries high pricing risk if usage exceeds estimates, and all three contracts face Continuing Resolution vulnerability in FY2027 budget negotiations.

3 total filings
· daily

Mega Contracts Monitor ($100M+) — May 22, 2026

This digest covers $726.2 million in mega-contracts ($100M+) awarded entirely by civilian agencies, with zero defense-related obligations. The dominant theme is civilian IT modernization and infrastructure support, led by General Dynamics Information Technology's $296.8M GSA engineering services award (though parent entity ambiguity and negative outlayed funding raise execution questions) and Carahsoft Technology Corp's $104.4M USDA Salesforce enterprise license agreement signaling sustained SaaS adoption. The highest-conviction signal is Carahsoft's $277M ceiling potential, indicating strong upside if options are exercised. Key risks include the negative outlayed amount on the GDIT contract and the fixed-price structure on both the Carahsoft and LMI Consulting awards, which shift cost risk to contractors. No bullish or bearish signals were identified; all four contracts are rated neutral with an average signal strength of 5.3/10.

4 total filings
· daily

High-Value Federal Grants ($5M+) — May 22, 2026

This digest covers $913.4 million in high-value federal grants awarded on a single day, with zero defense-related contracts, underscoring a purely civilian procurement theme. The dominant agency is the Department of Homeland Security (two awards totaling $267.5 million), followed by GSA ($296.8 million), VA ($153.1 million), USDA ($104.4 million), and State ($91.7 million). The highest-conviction signal is Akumen, Inc.'s $91.7 million sole-source 8(a) award from State, offering revenue certainty with limited competitive pressure. A key risk is the General Dynamics Information Technology contract, where a negative outlayed amount (-$13,398) on a $296.8 million obligation raises questions about execution status or accounting adjustments.

6 total filings
· daily

General Federal Contracts — May 22, 2026

This digest covers six civilian-agency contracts totaling $913.4 million, with zero defense-related awards, underscoring a non-DoD procurement focus. The dominant theme is IT modernization and border security infrastructure, led by General Dynamics Information Technology ($296.8M), LMI Consulting ($172M), and GOVCIO ($153.1M). The highest-conviction signal is Akumen, Inc.'s $91.7M sole-source 8(a) award from the State Department, which offers revenue certainty via non-competitive advantage. Key risks include execution pressure on Davenport Aviation's $95.5M firm-fixed-price helicopter contract and the negative outlayed amount on the General Dynamics award, which may indicate funding or performance issues. Investors should watch for option exercises on Carahsoft's $277M USDA Salesforce deal and the June 2024 end date of the General Dynamics contract for recompete signals.

6 total filings
· daily

S&P 500 Technology Sector SEC Filings — May 22, 2026

The May 22, 2026, S&P 500 Technology filings present a mixed picture dominated by annual meeting results and capital events, with limited operational data but several critical strategic signals. Zoom Communications stands out as the sole filing with meaningful period-over-period financial data, reporting a robust 67% YoY net income surge to $426M driven by improving operating leverage and investment gains, though its cash position declined sharply by 30% due to aggressive buybacks. The SPAC filing from Snow Rothschild Acquisition Corp. seeks $200M with significant dilution risks for public investors, while United Community Banks' acquisition of Peach State Bancshares at a $789M asset base signals consolidation in regional banking. Insider activity is absent from these filings, but director election results reveal notable shareholder dissent at SBA Communications (Laurie Bowen with 11.3% against), ServiceNow (Eric Yuan with 22.7% against), and Community Bancorp (17% broker non-votes), suggesting governance concerns. Capital allocation trends show a mix of modest dividend increases (Richmond Mutual at $0.15/share) and aggressive buybacks (Zoom reducing shares 1.9% sequentially). The overall portfolio theme is one of corporate governance alignment through annual meetings, with Zoom's operational strength providing the most actionable financial insight.

6 high priority 5 medium 11 total filings
· daily

Nasdaq 100 Stocks SEC Filings — May 22, 2026

This batch of 17 NASDAQ-100 filings reveals a diverging landscape: while stalwarts like Amazon and PepsiCo show procedural strength and solid credit access, emerging and transitioning companies (Welsbach/Evolution Metals, Faraday Future, Zoom) are reporting dramatic financial swings, high cash burn, or strategic inflection points. A clear period-over-period theme is the widening loss profiles at newer public entities—Welsbach/Evolution Metals swung from an $18M loss to a $440M GAAP loss—driven by non-cash fair value charges tied to complex post-business-combination accounting, obscuring underlying operational progress. Conversely, Zoom delivered a standout 67% YoY net income surge on improved margins and cost discipline, signaling maturation from growth to profitability mode. Insider activity is minimal across the filings, but shareholder voting dissent (e.g., 10.7M shares against one director at SBA, 7% negative say-on-pay at CCC) and high broker non-votes (17% at Community Bancorp/VT) suggest pockets of governance friction. Capital allocation patterns show a mix: dividend declarations (Richmond Mutual, Community Financial), share buyback continuation (Zoom), and merger expansion (United Community Banks acquiring Peach State). Forward-looking catalysts include Faraday Future's raised shipment target (1,500 units, +50%) and a $100M convertible note facility for Evolution Metals, alongside a shelf registration from Critical Metals Corp., signaling future capital raises. The most actionable insights cluster around three high-materiality narratives: Zoom’s profitability pivot, Faraday Future's listing survival gambit, and Evolution Metals' capacity ramp.

5 high priority 12 medium 17 total filings
· daily

S&P 500 Financials Sector SEC Filings — May 22, 2026

The 50 filings from S&P 500 Financials and adjacent sectors reveal a market bifurcated between a handful of high-growth, cash-generating winners and a larger cohort of deeply distressed micro-cap companies facing existential liquidity crises. Dominant themes include a wave of SPAC and blank-check IPOs seeking high-growth sectors, significant M&A activity in energy (Dominion/NextEra) and biotech (Galera/Obsidian), and a clear divergence in capital allocation where profitable firms like News Corp and Stifel Financial return capital via buybacks while distressed entities like Trutankless and Transuite burn cash. Period-over-period data highlights severe revenue declines at Allied Gaming (-12.2% YoY) and Booz Allen Hamilton (-6.4% YoY), contrasted with strong growth at Take-Two Interactive (+18.2% YoY) and Vodafone (+8.0% YoY). Insider activity is sparse but notable, with significant opposition to equity plans at Stifel and GameStop signaling governance concerns. The most critical developments are the Dominion/NextEra $2.24B termination fee risk, the failed Estée Lauder/Puig deal, and the Nasdaq non-compliance at Allied Gaming, all of which create immediate market implications for investors.

26 high priority 24 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — May 22, 2026

The 50 filings for the S&P 500 Consumer Staples sector on May 22, 2026, reveal a sector in transition, marked by a significant failed M&A attempt in the beauty space, a major debt refinancing by a beverage giant, and mixed operational performance from a wholesale club. The most critical development is the termination of merger talks between Estée Lauder and Puig, a high-materiality event that removes a major consolidation catalyst and signals potential strategic uncertainty for both companies. PepsiCo's refinancing of $10B in credit facilities demonstrates proactive balance sheet management, while BJ's Wholesale Club's strong revenue growth but declining profitability highlights the margin pressure from pricing investments and rising costs. A clear theme of shareholder activism is evident, with several companies (BlackRock, Welltower, Travelers) experiencing significant dissent on say-on-pay and other proposals, indicating heightened investor scrutiny on governance and compensation. The sector also shows a bifurcation between companies successfully growing revenue (CorVel, Cosmos Health) and those facing operational headwinds (Selectis Health). Overall, the filings suggest a cautious but active environment where capital allocation, governance, and strategic clarity are key differentiators.

15 high priority 35 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — May 22, 2026

The 50 filings from the S&P 500 Industrials stream reveal a sector in transition, with a pronounced divergence between established industrial powerhouses and cash-burning special purpose acquisition companies (SPACs) and pre-revenue biotechs. A dominant theme is the acute financial distress among SPACs, with Pyrophyte Acquisition Corp. reporting a swing to a $6.1M net loss from a $299K profit, driven by a $5.3M unfavorable change in derivative warrant liabilities and massive shareholder redemptions. Similarly, Welsbach Technology Metals Acquisition Corp. posted a staggering $440.3M net loss, though this was largely non-cash. In contrast, established industrial firms like Amphenol and GE Vernova show stability with strong shareholder support for management, though notable dissent on executive compensation (e.g., 7.7% against at Amphenol) signals governance concerns. Capital allocation is mixed: FedEx is proactively reducing debt by redeeming €354.9M in notes, while Generation Income Properties is selling assets (Starbucks and Dollar Tree properties) to shore up liquidity, yet still reports significant net losses. Insider activity is sparse in this batch, but the lack of insider buying amidst the SPAC distress is a telling negative signal. The most actionable insights revolve around the imminent delisting risks for TransCode Therapeutics and Terra Innovatum, the failed M&A between Estée Lauder and Puig, and the ongoing financial deterioration of several SPACs, which presents both risks and potential opportunities for activist investors or acquirers of distressed assets.

20 high priority 30 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — May 22, 2026

The 7 filings from the S&P 500 Energy sector and related companies reveal a mixed landscape dominated by corporate governance actions and a major M&A completion. The most significant development is Devon Energy's completed merger with Coterra Energy, creating a larger, more diversified E&P player, though pro forma statements offer limited forward guidance. Capital allocation trends are divergent: Williams-Sonoma (a retail outlier in this energy-focused stream) aggressively returned capital via buybacks and dividends, depleting cash, while Houlihan Lokey showed strong revenue growth but rising costs and declining cash flow. Insider activity was notably absent across all filings, limiting conviction signals. Governance actions at XOMA Royalty and shareholder meeting results at NeoGenomics and Targa Resources showed strong support for management, though with pockets of dissent. The lack of forward-looking guidance and operational metrics in most filings suggests a period of digestion post-merger and pre-earnings season, with the key catalyst being the final Spectrum Acquisition Closing for Hughes Satellite Systems in late 2027.

4 high priority 3 medium 7 total filings